ページ2 - 最高の化学療法医師 - トップ140名の医師

Activities • Prevention, research and early diagnosis of cancer • Palliative care in cancer • Cytotoxic chemotherapy • Hormontherapy • Targeted treatment • Immunotherapy Education • 2004 -2010 - Istanbul University, Istanbul faculty of medicine • 2011-2015 - Istanbul University, Istanbul faculty of medicine, internal medicine specialist • 2013-2014 - Cleveland Clinic Endocrinology Department, research associate • 2016-2019 Bezmiâlem Foundation University Medical Oncology Subdivision • Dissertation: Prognostic value of absolute monocyte count in patients with mantle cell lymphoma. • Subdivision Dissertation: An effect of adjuvant chemotherapy on lipid profile and anthropometric parameters in patients with breast and colon cancer. Publications • Circulating Thyroid-Stimulating Hormone Receptor Messenger RNA as a Marker of Tumor Aggressiveness in Patients with Papillary Thyroid Microcarcinoma. Aliyev A, Gupta M, et al. Endocr  18. • The utility of peripheral thyrotropin receptor mRNA in the management of differentiated thyroid cancer. • Aliyev A, Soundararajan S, Bucak E et al. Surgery.  • Diagnostic accuracy of circulating thyrotropin receptor messenger RNA combined with neck ultrasonography in patients with Bethesda III-V thyroid cytology. Aliyev A, Patel J, Brainard J, et al. Surgery.2016 Jan;159(1):113-7. doi: 10.1016/j.surg.2015.06.063. Epub 2015 Oct 9. • Role of Urotensin-2 in 5-Fluorouracil-Related Arterial Vasoconstriction in Cancer Patients. Seker M, Aliyev A, et al. Oncol Res Treat. Epub 2018 Aug 20. • Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naive breast cancer: real-life practice outcomes. Esin E, Oksuzoglu B, Bilici A, Aliyev A. Cancer Chemother Pharmacol.2019 Jan; Epub 2018 Oct 30. • Usefulness of serum M30 and M65 levels to predict response to neoadjuvant chemotherapy in patients with breast cancer. Turk HM, Aliyev A, Celik RS. Curr Probl Cancer.2019 Jul 29. pii: currproblcancer.2019.06.009. • Prognostic impact of primary tumor location on survival in metastatic colorectal cancer patients: A single center experience. Tarik Demir, Murat Araz, Altay Aliyev. Medicine Science International Medicine Journal. • Oral presentations 

Experience

2022 PRIVATE MEDIPOL BAHÇELİEVLER HOSPITAL

2021 - 2021 Prof. Dr. Cemil Taşçıoğlu City Hospital, Medical Oncology Clinic Education Officer

2021 - 2021 Prof. Dr. Cemil Taşçıoğlu City Hospital

2020 - 2021 Yüzüncü Yıl University Faculty of Medicine

2020 - 2021 Head of the Department of Medical Oncology, Yüzüncü Yıl University Faculty of Medicine, Assoc. Dr.  

2018 - 2021 Lecturer - Yüzüncü Yıl University Faculty of Medicine, Head of Medical Oncology Department  

2018 - 2021 Yüzüncü Yıl University Faculty of Medicine

2015 - 2018 University of Health Sciences, Okmeydanı Training and Research Hospital

2015 - 2018 University of Health Sciences, Okmeydanı Training and Research Hospital, Medical Oncology Clinic, Sub-branch assistant

2012 - 2015 Kanuni Sultan Süleyman Training and Research Hospital, Internal Medicine specialist

2012 - 2015 Suleiman the Magnificent Training and Research Hospital,

2008 - 2012 Haseki Training and Research Hospital

2006 - 2008 Kızıltepe No. 3 Health Center General Practitioner.

Education

2018

İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji

2018

İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji, İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji

2012

İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları, İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları

2012

İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları

2007

Uludağ Üniversitesi Tıip Fakültesi, Tıip Fakültesi, Uludağ Üniversitesi Tıip Fakültesi, Tıip Fakültesi

2023 – Istanbul Gaziosmanpaşa Taksim Education and Research Hospital – General Surgery Clinic Associate Professor

2013 – Istanbul Gaziosmanpaşa Taksim Education and Research Hospital – General Surgery Clinic Specialist

2008 – 2013 Private Medical Park Fatih Hospital, General Surgery Specialist - Deputy Chief Physician

2005 – 2007 Private Gelişim Hospital – General Surgery Specialist

2003 – 2005 Private Istanbul Şafak Hospital – General Surgery Specialist - Chief Physician

2002 – 2003 ISTANBUL HASEKİ EDUCATION AND RESEARCH HOSPITAL – General Surgery Clinic Assistant Physician

1998 – 2002 Ankara Education and Research Hospital – General Surgery Clinic Assistant Physician

1998 – Health Sciences University – Istanbul Haseki Health Application and Research Center – Medical Specialization

1991 – Gazi University Faculty of Medicine – Bachelor’s Degree

Certificates

IGM Diagnosis, Treatment Workshop, Granulomatous Mastitis, Kocaeli, Certificate, 07.10.2023 (National)

ibreast 51- Free Flap Reconstruction, Breast Cancer Surgery, Online, Certificate, 30.09.2023 – 30.09.2023 (International)

ibreast 50- Triple Negative Breast Cancer, Breast Cancer, Online, Certificate, 02.09.2023 -02.09.2023 (International)

ibreast 49- Implant Based Reconstruction, Breast Cancer, Online, Certificate, 12.08.2023 -12.08.2023 (International)

ibreast 48- DCIS, İbreast 48- DCIS, Online, Certificate, 15.07.2023 -15.07.2023 (International)

ibreast 47- Conference Updates, Breast Cancer, Online, Certificate, 25.06.2023 -25.06.2023 (International)

ibreast 46- Margin Revisited, Breast Cancer, Online, Certificate, 10.06.2023 -10.06.2023 (International)

1. International 4. National Breast Surgery Congress, Breast Surgery, Ürgüp, Certificate, 05.05.2023 – 07.05.2023 (International)

ibreast 44- HER2 Positive Disease, Breast Cancer, Online, Certificate, 29.04.2023 -29.04.2023 (International)

St-Gallen 2023, St-Gallen Congress Summary Meeting, Istanbul, Certificate, 01.04.2023 -01.04.2023 (National)

ibreast 43- Save The Nipple, Breast Cancer, Online, Certificate, 25.03.2023 -25.03.2023 (International)

ibreast 42-Chest Wall Perforator Flap Revisited, Breast Cancer, Online, Certificate, 25.02.2023 -25.02.2023 (International)

ibreast 41- High Risk And B3 Lesions, Breast Diseases, Online, Certificate, 28.01.2023 -28.01.2023 (International)

15. New Approaches in Breast Cancer Education Meeting, Breast Cancer, Istanbul, Certificate, 07.01.2023 – 08.01.2023 (National)

Articles she wrote and took part in;

1.YILDIRIM EMİNE, BEKTAŞ SİBEL, YETİŞ FIRAT, YILDIZ EREN OZAN, ÖZDEMİR MUHAMMED, KOMUT NESLİHAN, ÇALIK MUSTAFA, ER AHMET MUZAFFER. Correlation between breast and axillary pathologic complete response after neoadjuvant chemotherapy in breast cancer. Annali Italiani di Chirurgia, 2023

2.UZUN NEDİM, YILDIRIM EMİNE. Relationship Between Toilet Type and Hemorrhoids. Bezmialem Vakif University, 2022

3.YILDIZ EREN OZAN, YILDIRIM EMİNE, ORHUN ERDOĞAN KIVILCIM, ERYILMAZ İKLİL, YÜNLÜEL EMİR MEHMET, YETİŞ FIRAT, ULUKENT SUAT CAN. The effect of the covid 19 pandemic on the number of patients treated for acute and complex acute appendicitis. Annali Italiani di Chirurgia, 2202

4.YILDIRIM EMİNE, BEKTAŞ SİBEL, ÖZDEMİR MUHAMMED, KARAGÜLLE AHENK, ER AHMET MUZAFFER, UÇAR NEŞE. Upgrade Rates of DCIS, Intraductal Papilloma, and the Other High-risk Breast Lesions. Hamidiye Medical Journal, 2022
 

5.ÖZKAN GÜMÜŞKAYA PERİHAN, ALTUN ÖZGÜR, KARAKÜTÜK YÜZTAŞ NUR, ÖZSOY NESLİHAN, AYDIN TUTAK GÜLTEN, YILDIRIM EMİNE, ADAŞ MİNE, KÜÇÜK MEHMET. COVID-19 Pnömonisi Sonrası AntiHBs Değerlerindeki Değişiklikler. Journal of Contemporary Medicine, 2022;12(4), 

6.KOMUT NESLİHAN, BEKTAŞ SİBEL, YILDIRIM EMİNE. The relationship of tumor budding with GOLPH3 expression and histopathological prognostic parameters in colorectal adenocarcinoma. Annals of Diagnostic Pathology 2022 Jun;58:151933. 

7.KAYADİBİ YASEMİN, UÇAR NEŞE, AKAN YEŞİM NAMDAR, KAYA MEHMET FATİH, YILDIRIM EMİNE, ALADAĞ KURT SEDA, SOYLU BOY FATMA NUR, TAŞKIN FÜSUN, İÇTEN GÜL ESEN. Magnetic resonance imaging findings associated with recurrence in idiopathic granulomatous mastitis. Clinical Imaging, 2022

8.YILDIRIM EMİNE, KEĞİN MURAT, ÖZDEMİR MUHAMMED, BEKTAŞ SİBEL, PELEN ZEKERİYA, ER AHMET MUZAFFER. Neoplasms of theAppendix; Single Institution and Ten-Year Experiences Results. Turkish Journal of Trauma and Emergency Surgery, 2022;28(3), 352-360

9.YILDIRIM EMİNE, YILDIZ EREN OZAN, ERYILMAZ İKLİL, ER AHMET MUZAFFER, BEKTAŞ SİBEL. Comparison of excised breast volume, re-excision rate and margin positivity in breast-conserving surgery in breast cancer patients using and not using neoadjuvant chemotherapy. Journal of Surgery in Medicine,2022;6

10.YILDIRIM EMİNE, BEKTAŞ SİBEL, PELEN ZEKERİYA, YANIK İREM, ER AHMET MUZAFFER, ÇENGEL FERHAT, ÖZKAN GÜMÜŞKAYA PERİHAN. Histopathological, Radiological, and Demographic Factors Predicting the Response to Neoadjuvant Therapy for Rectal Cancer. Journal of Gastrointestinal Cancer, 2022;53(1)

11.KAYADİBİ YASEMİN, KOÇAK BURAK, UÇAR NEŞE, AKAN YEŞİM NAMDAR, YILDIRIM EMİNE, BEKTAŞ SİBEL. MRI Radiomics of Breast Cancer: Machine Learning-Based Prediction of Lymphovascular Invasion Status. Academic Radiology, 2022;29(1), 126-134.

12.YILDIRIM EMİNE, UÇAR NEŞE, YETİŞ FIRAT, KAYADİBİ YASEMİN, BEKTAŞ SİBEL. Diagnostic performance of breast imaging with ultrasonography, magnetic resonance and mammography in the assessment of residual tumor after neoadjuvant chemotherapy in breast cancer patients. Journal of Surgery and Medicine, 2022;6(1), 43-48

13.YILDIRIM EMİNE, BEKTAŞ SİBEL, GÖKTAŞ AYDIN SABİN, ER AHMET MUZAFFER, YANIK İREM, ÖZKAN GÜMÜŞKAYA PERİHAN, YILMAZ BARBAROS UTKU, BİLİCİ AHMET, ÖNCEL MUSTAFA. Factors Predicting Response to Neoadjuvant Chemotherapy in Locally Advanced Gastric Cancer. Journal of Istanbul Faculty of Medicine / İstanbul Tıp Fakültesi Dergisi, 2022;85(1), 41-50. 

14.YILDIRIM EMİNE, Pelen Zekeriya, KEĞİN MURAT, UÇAR NEŞE, KAYADİBİ YASEMİN, GÜNDOĞAR ÖZGECAN. Evaluation of the Reliability of Preoperative Ultrasonography and Ultrasonography-Guided Fine Needle Aspiration Biopsy in Axillary Staging in Patients With Breast Cancer. Journal of Academic Research in Medicine, 2021;11(3), 269-276., 

15. KAYADİBİ YASEMİN, UÇAR NEŞE, KAYA MEHMET FATİH, YILDIRIM EMİNE, BEKTAŞ SİBEL. Characterization of Suspicious Microcalcifications on Mammography Using 2D Shear-Wave Elastography. Ultrasound in Medicine & Biology, 2022;47(9), 2532-2542. 

16.KAYADİBİ YASEMİN, TEKCAN ŞANLI DENİZ ESİN, UÇAR NEŞE, YILDIRIM EMİNE, ŞANLI AHMET NECATİ. Evaluation of the Appearance Characteristics of Suspicious Microcalcifications Detected by Ultrasonography. Journal of Academic Research in Medicine, 2022;11(2), 199-205. 

17.YILDIRIM EMİNE, ÖZER HİLAL, ÖZER İLTER, KOYUNCU ADİL, YILDIRIM TİMUR. The Effects on Bacterial Translocation and Tissue Damage of Selenium Treatment in an Experimental Intestinal Ischaemia-Reperfusion Model. Turkish Journal of Trauma and Emergency Surgery, 2021;27(4), 389-394. 

18.YILDIRIM EMİNE, AKBAŞ PELİN, ORHUN ERDOĞAN KIVILCIM, BEKTAŞ SİBEL, ÖZKAN GÜMÜŞKAYA PERİHAN, ER AHMET MUZAFFER, PALTURA CEKİ. The comparison of the histopathological results of the thyroid fine-needle aspiration biopsies in the 795 patients with thyroidectomy. Diagnostic Cytopathology, 2021

Children's Hematologist. Specialist in bone marrow transplantation

Dr. Jaume Mora Graupera is a pediatric oncologist specializing in the treatment of neuroblastomas, gliomas, Ewing's sarcomas, and Wilms' tumors. He is the Director of the Hematology Oncology Department and Developmental Tumors Laboratory at Sant Joan De Déu - Barcelona Children’s Hospital. He received his medical degree from the University of Barcelona, went on to complete specialty training in pediatrics and fellowships in pediatric hematology oncology and molecular pathology of pediatric cancer at Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center in the USA. He has won multiple awards and is a member of various medical organizations.

Oncologist-mammologist

Treatment of mastopathy, which causes pain and swelling of the mammary gland

Treatment of large breast cysts without surgical aspiration

Treatment of duct ectasia (dilation) and galactorrhea

Obtaining a smear from the secretion of the mammary gland

Treatment of adenosis and other precancerous diseases of the mammary gland

Biopsy of pathological formations on the skin of the mammary gland

Hormonal treatment for breast cancer

Treatment of precancerous diseases of other organs

Cancer Treatment

Symptomatic treatment of cancer patients

Mistletoe therapy and cancer treatment with high doses of vitamin C.

Elimination of complications and side effects of chemotherapy and radiation therapy

Pain Treatment for Cancer Patients (Natural Pain Relief and Life Extension)

Participant of many conferences and seminars with the participation of German doctors in Azerbaijan, as well as in Germany and Turkey.

シナン・カラアスラン医師は、アナドル医療センターにて乳癌、大腸癌、泌尿生殖器癌の診療を専門としている。

• 腫瘍内科における29年の経験年以上の診療経験
• イスタンブール大学チェッラパシャ医学部でのフェローシップ修了
• トルコ腫瘍内科学会会員
• JCI認定取得済みのアナドル医療センター勤務

ドクター ベトゥル・タビル は、小児血液腫瘍学の教授であり、小児骨髄移植における世界的な専門家です。

タビル医師が患者から信頼される理由：

• 卓越した治療実績を持つ医師 ― 白血病の小児500名以上の治療に成功し、100名以上の小児に骨髄移植を実施しています。
• 小児における極めて稀な血液疾患の専門家：先天性赤芽球性ポルフィリン症、免疫不全症、遺伝性血液疾患。
• 受賞歴のある研究者 ― 小児血液がん治療における顕著な業績に対し、トルコ血液学会賞を受賞しています。
• 国際学術誌における150本以上の論文および1,700件以上の被引用数を誇り、新たな治療法の開発を継続的に行っています。
• 小児における悪性および非悪性疾患に対する高度な骨髄移植の第一人者です。
• 28年にわたる主要医療機関での経験 ― ハセッテペ大学、Ankara Children's Hospital、Memorial Şişli。
• オンライン診療を実施 ― 自宅にいながら、卓越した小児血液専門医の専門的見解を得ることが可能です。

セルカン・ケスキン医師は、メモリアル・シシュリ病院にて高度化学療法および免疫療法を専門とする、25年の経験の経験を持つ優秀な腫瘍内科医です。

• 腫瘍内科専門医資格試験においてトルコ国内第1位を獲得
• 第19回全国がん学会議にてベストポスター賞を受賞
• 世界有数の腫瘍学会であるASCOおよびESMOの会員
• トルコの主要医療機関にて内科および腫瘍内科の専門研修を修了

Prof. Şeref Kömürcü は、アナドル医療センターにおいて乳がん、大腸がん、肺がんを専門とする、ECFMGおよびESMO認定の腫瘍内科医です。

• 腫瘍内科における33年の経験の臨床経験
• がん治療に関する110本以上の論文を発表
• ギュルハネ軍事医学アカデミー教授
• ASCO、ESMOおよびその他の主要腫瘍学会の会員

イェシム・ユルドゥルム教授は、アナドル医療センターにてがん免疫療法および分子標的療法を専門とし、最先端の腫瘍学的治療において第一線で活躍しています。

• 国際的な学術論文および著書への寄稿80件以上
• ESMO・ESOの正会員（腫瘍学分野の主要学会）
• ハリチ大学教授として次世代の腫瘍専門医を育成
• 乳がん、消化器がん、肺がんを専門とする
• イスラエルのランバム医療センターおよび英国のマウント・バーノン病院にて研鑽を積む

学歴・経歴

• エーゲ大学医学部、1978年
• 小児科専門医取得、1982年
• 小児腫瘍学専門医取得、2002年（EU医学部）
• 小児血液腫瘍学、2012年（EU医学部）
• テペジックEAH 副科長、1988年
• テペジックEAH 科長、1993年
• 准教授資格取得、1995年
• 教授就任、2002年
• エーゲ大学医学部、講師、1998年〜2022年
• ヨーロッパ医学部、小児科学教室、2009年〜2018年
• テペジック教育計画・調整委員会委員（1993年〜1998年）
• SSIテペジック病院倫理委員会委員長（1996年〜1998年）
• トルコ小児血液学会「骨髄移植ワーキンググループ 共同委員長」（2002年〜2006年）
• トルコ小児血液学会「骨髄移植ワーキンググループ」（2006年〜2008年）
• トルコ小児血液学会 — 骨髄移植オンラインデータ登録システム担当、2007年〜現在
• エーゲ大学再生医療・幹細胞委員会委員長、2011年〜2021年

学術団体会員

• トルコ医師会、イズミル支部およびコジャエリ支部
• トルコ国立小児科学会 — イズミル
• 欧州骨髄移植グループ（EBMT）；エーゲ大学小児骨髄移植部門は、2007年6月に欧州骨髄移植グループ（EBMT）より認定を受けた。
• トルコ小児血液学会 — 理事会メンバー、2期（2005年〜2009年）
• トルコ血液学会 — 理事会メンバー、2期（2001年〜2005年）
• トルコ小児腫瘍学会
• 骨髄移植財団（KITVAK）評議員会メンバー

創設した部門

1- SSIテペジック病院 小児腫瘍科（1990年）
2- SSIテペジック病院 小児骨髄移植部門（1992年）
3- ヨーロッパ医学部 小児骨髄移植部門（1998年）
4- 小児研究雑誌 創刊者、2014年；SCI申請は2022年に提出

設立に貢献した移植部門

1. イズミルBUÇ病院 小児骨髄移植部門（2019年）
2. ÜmraniyeEAH 小児骨髄移植部門（2020年）
3. カーヌーニー・スルタン・スレイマンEAH 小児骨髄移植部門（2020年）（チャム・サクラEAH骨髄移植部門へ移管）

受賞歴

• 骨髄幹細胞移植患者における血栓症関連パラメータ、小児血液学会議、トラブゾン、2003年
• 幹細胞におけるCD133抗原：小児血液学会議2005年 研究賞
• 発熱性好中球減少症患者におけるToll様受容体の役割、最優秀ポスター賞、トルコ血液学会議2008年、チェシュメ・イズミル
• 小児における造血幹細胞移植の全国的活動 — 口頭発表、第2位、トルコ血液学会造血幹細胞移植会議、2022年、アンタルヤ

著作・出版物

Kansoy S.「骨髄・幹細胞移植。小児の健康と疾患」、第1版、EU医学部出版、1999年、イズミル

Kansoy S. 重症型サラセミアIIIにおける骨髄移植。エーゲ・サラセミアデーズ書籍、2000年、イズミル

Kansoy S. トルコにおける小児KIT移植センターの基準。小児急性白血病、アンタルヤ2000年：73-5

Kansoy S. 小児における晩期副作用。Bone Marrow Transplantation Journal of Turkish Clinics 特別号、2003年

Kansoy S. 骨髄・幹細胞移植における幹細胞の応用。小児腫瘍看護学テキスト、イズミル、2005年

Kansoy S. 幹細胞源としての臍帯血。幹細胞特別号、Turkish Clinics、2008年

Kansoy S. リンパ腫における幹細胞移植。一般小児科書籍、Enver Hasanoğlu教授編、2009年

Kansoy S.、Aksoylar S. 小児における骨髄移植。小児科学、2014年および2017年

Kansoy S. 横紋筋肉腫。小児科学、2014年および2017年

Kansoy S. 臨床所見に基づく腫瘍性疾患を有する小児へのアプローチ。小児科学、2014年および2017年

11. Çetingül N.、Kansoy S.、Kantar M. 腫瘍性疾患。小児科学（A. Kura編）、641-672、エーゲ大学出版、イズミル、1999年。（1.05点）

Kansoy S.、M. Kantar. 頭部・顔面・眼の診察。義肢装具士の身体診察と症状に関する情報（A. Kura編）

Kantar M. 腫瘍学における代謝性緊急症の問題。小児期における腫瘍学的緊急症と支持療法（N. Çetingül、S. Kansoy編）、15-24、Meta Basım、イズミル、2003年

トルコにおける臍帯血移植。HEMATOLОГ、2016年

Kansoy S. 小児中枢神経系腫瘍、小児科学、2014年および2017年

小児急性骨髄芽球性白血病およびその治療。小児腫瘍学教科書、Poplack's Turkish版、2020年

小児における造血幹細胞移植の全国的活動、2020年

小児における幹細胞移植の適応、Turkish Clinics — 国際版、2020年

多数の国際学術誌における研究論文・原著論文に加え、インパクトファクターの高い一部の学術誌において国際多施設共同研究にも参加している。

MDアンダーソンおよびアンスティチュ・ジュール・ボルデで研鑽を積んだテッリ医師は、イスタンブール・フローレンス・ナイチンゲール病院に最高水準の腫瘍学の専門知識をもたらしています。

• 化学療法を中心とした内科腫瘍学を専門とする
• フェローシップ修了者であり、臨床研究における国際的な経験を有する
• トルコ有数のがん治療センターに勤務

Prof. Dr. Şebnem İzmir Güner was born in 1970 in Istanbul and took her first steps in her medical career at Istanbul University Faculty of Medicine. Successfully completing her undergraduate and medical education here between 1987-1993, Güner received her internal medicine specialty training at Istanbul University Cerrahpaşa Faculty of Medicine from 1995 to 2000. Deepening her interest in hematology, Prof. Dr. Güner completed her hematology subspecialty training at Cerrahpaşa Faculty of Medicine again between 2003-2006, solidifying her expertise in this field.
Prof. Dr. Güner’s professional journey began as an internal medicine specialist at Istanbul Education and Research Hospital from 2000 to 2003. She established the Hematology Clinic at the same hospital from 2006 to 2010 and served as the responsible physician. Here, she developed innovative approaches in the treatment of patients and made significant contributions to the field of hematology. From 2010 to 2016, she established the Hematology Clinic, Therapeutic Apheresis, and Adult Bone Marrow Transplantation Center at Medicalpark Bahçelievler Hospital and served as the responsible physician. During this period, she conducted studies that set national and international standards in the field of hematology.
Between 2016-2018, Prof. Dr. Güner took on similar roles at Şişli Kolon International Hospital, where she was also the founder and responsible physician of the Hematology Clinic, Therapeutic Apheresis, and Adult Bone Marrow Transplantation Center. Güner, who became an associate professor in 2017, obtained her professorship title in 2023. Between 2019-2024, she worked at Memorial Şişli Hospital in the Hematology Clinic, Therapeutic Apheresis, and Adult Bone Marrow Transplantation Center.
Prof. Dr. Şebnem İzmir Güner is recognized for her scientific contributions, with over 19 articles published in international peer-reviewed journals. Additionally, she has over 18 articles published in national peer-reviewed journals and 51 presentations at national scientific meetings that have been published in proceedings books. She has also made a name for herself in the academic world with over 18 presentations at meetings and published in proceedings books. Güner, who has held positions on the boards of domestic hematology associations and has active memberships, has crowned her success with more than three awards given at universities and conferences.
Prof. Dr. Şebnem İzmir Güner, who speaks English and German, is also recognized as an educator. In this capacity, she has contributed to the training of young doctors in the field of hematology, providing education to research assistant doctors and students.
Prof. Dr. Şebnem İzmir Güner has established a respected place in the field of hematology with her achievements and scientific contributions throughout her professional life, continuing her career as a physician who inspires her patients and colleagues.

MEDICAL INTERESTS

• Leukemia
• Lymphoma
• Multiple myeloma
• Bone marrow transplantation
• Anemia
• Bleeding and coagulation disorders
• Hemophilia

Prof. Dr. Sezer Sağlam is a medical oncologist at Gayrettepe Florence Nightingale Hospital. He specializes in gastrointestinal and breast cancers. He has contributed to cancer care through research, especially with his study on the best timing for surgery after neoadjuvant therapy in rectal cancer. This work has influenced global treatment protocols.

Dr. Sağlam has led clinical trials in targeted therapies and precision medicine. His research on liver-transplanted patients with hepatocellular carcinoma was nominated for the 2024 International Best Researcher Award. He is a member of ASCO, ESMO, and ENET. Dr. Sağlam provides personalized and evidence-based oncology care.

Assoc. Prof. Dr. Oğuzhan BABACAN completed his undergraduate, specialty and sub-specialty education at GATA Military Medical Faculty/Ankara. After becoming a specialist in Pediatrics, he worked in the field of Social Pediatrics for two years, where Healthy Baby Monitoring and vaccine follow-up were carried out. Then, she completed her subspecialty training in Pediatric Hematology and Oncology and continued her studies in the field of pediatric blood and cancer diseases. In addition to the treatment of children suffering from leukemia, lymphoma, solid tumors and other blood diseases, she has been working in the Bone Marrow Transplantation (Transplant) Unit for 13 years in Allogeneic (unrelated and intrafamilial), Autologous (from the patient himself) and Haploidentical (partially HLA compatible) hematopoietic stem cell transplantation. In 2018, he received the title of Associate Professor in the field of Pediatric Hematology and Oncology Science/Art.

MEDICAL AREAS OF INTEREST

Healthy baby follow-up and vaccinations

Lymph node enlargement

Pediatric patients with anemia (anemia)

Leukemia

Lymphoma

Bone Marrow Transplant

ITP

Thalassemias

Hemophiliacs

Solid tumors

Hemangioma

Childhood blood disorders

Children with frequent infections

Fever of unknown origin

Malnutrition in children

Dr. Francesc Cobo Valien graduated from the Faculty of Medicine of the University of Barcelona in 1990.

He received his specialization in oncohematology at the Hospital Clínic de Barcelona in 1995. He combined medical practice and research activities in the period 1996-2002.

He received his Doctor of Medicine degree from the University of Barcelona in 2002.

Dr. Kobo continues his research and has been awarded grants:

•Interdepartmental Commission for Innovation of the Generalitat de Catalunya

•Scholarship Fund Universitaria Agustí Pedro i Pons

•Farreras Valentí & Schering Plough School of Hematology Scholarship

•Award for the best report at the Council of the Spanish Hematology Association

•Grant from the Catalan Society of Hematology

Specialization:

•Lymphoma

•Acute leukemia

•Chronic leukemia

•Autoimmune pancytopenia

ムスタファ・オズドアン教授は、トルコのメモリアル・アンタルヤ病院の腫瘍内科部門を率いており、26年の経験以上の経験を持ちます。

• 腫瘍内科を専門とし、アクデニズ大学にて研鑽を積む
• がん治療に関する論文を40本以上発表
• 欧州臨床腫瘍学会（ESMO）などの権威ある学術団体の会員
• 臨床および学術の両分野において豊富な経験を有する

Dr. Verges graduated in Medicine and Surgery from the University of Barcelona in 1980 and moved to Boston (USA) to conduct basic research in ophthalmology, obtaining a PhD in Biology from Harvard University and defending his doctoral thesis on the mechanisms of tear secretion, which would become the basis for understanding the pathology of dry eye syndrome (thesis presented in Barcelona, ​​1983) and which earned him the National Research Prize (1983).

Currently, Dr. Carlos Verges carries out his professional activity as the Director of the Ophthalmology Service of the Dexéus University Hospital, together with his entire medical team from the advanced ophthalmology department, where he has a high-quality technological, medical and surgical team.

His area of ​​interest is focused on the field of cataract and neurophysiological mechanisms of vision, especially in relation to sports.

Professional experience

1983-1986 Associate Professor, Department of Ophthalmology, Faculty of Medicine, University of Barcelona, ​​Spain

1986-1989 Head of the Anterior Segment Unit, Department of Ophthalmology, Barcelona Hospital Clinic, Spain.

1986-1991 Professor of Ophthalmology, Faculty of Medicine, University of Barcelona, ​​Spain.

1990-1992 Head of Ophthalmology Service, Hospital del Mar, Barcelona.

1989-1999 Head of the Ophthalmology Department, Sagrada Familia Clinic, Barcelona, ​​Spain.

From 2000 to present, President and CEO of the Dr. Carlos Verges Private Foundation.

2000-2007 Head of the Ophthalmology Department, Institut Universitari Dexeus, Barcelona, ​​Spain.

2007 – present General Director of the “Advanced Ophthalmology Department Dr. Verges”, Barcelona, ​​Spain.

2018-present President and Head of the Department of Ophthalmology. University Hospital Dexeus Quironsalud. Polytechnic University of Catalonia.

Awards :

- National Research Prize 1984. Ministry of Education and Science: "The mechanism of tear secretion. The importance of beta-adrenergic receptors in the lacrimation of the lacrimal glands."

- National Prize for the best doctoral dissertation, Shibre Medal, 1984 "Personal contribution to the study of labial secretion. Determination of beta-adrenergic receptors in tear cells"

- National Pharmaceutical Industry Award 1987: "Treatment of immunological rejection in corneal transplantation using cyclosporine A."

- American Society of Implant Refractive Surgery (ASCRS) Award for the best scientific video presented at the annual conference: "Pseudo-Real Housing". First Prize. Seattle, USA, April 1999.

- Award for the most important technical innovation of 1999 from the Spanish Society.

Implantation-refractive surgery. Speaking at the National Congress held in Madrid 1999.

- 2000 Best Scientific Contribution Award "Laser Non-Penetrating Deep Sclerectomy" presented at the American Academy of Ophthalmology Meeting, AAO - Dallas, USA, October 2000.

- Best Paper Award for “GDx Analysis of Retinal Nerve Fiber Layer Thickness after LASIK” presented at the American Society of Cataract and Refractive Surgery, ASCRS, May 2004, San Diego, USA.

- Finalist for the King Jaume I Prize for Basic Research, 2005, sponsored by the Board of Trustees of the Generalitat of Valencia and the Valencian Foundation for Advanced Research.

- Surgical Technical Video Award: "MICS under Vision ICL, The Hook Technique"

Presented at the IX International Congress of Cataract and Refractive Surgery, May/June 2006, Belo Horizonte, Brazil.

Membership in scientific societies

Member of the Executive Board of the International Society of Refractive Surgery (ISRS) and the American Academy of Ophthalmology (AAO).

Member of the editorial board of Ophthalmology Times. Europe.

Member of the editorial board of Cataract and Refractive Surgery (USA).

Member of the Editorial Board of Cataract and Refractive Surgery Today Europe.

Member of the European Society of Cataract and Refractive Surgery (ESCRS).

Scientific reviewer of the journal: Cornea, Journal of Cataract and Refractive Surgery, American Academy of Ophthalmology, Cataract and Refractive Surgery and Archives of the Spanish Society of Ophthalmology.